In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control study.

Kempton, C L; Soucie, J M; Miller, C H; Hooper, C; Escobar, M A; Cohen, A J; Key, N S; Thompson, A R; Abshire, T C

Kempton, C L; Soucie, J M; Miller, C H; Hooper, C; Escobar, M A; Cohen, A J; Key, N S; Thompson, A R; Abshire, T C.

Afiliación

Kempton CL; Aflac Cancer Center and Blood Disorders Service and Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA. christine.kempton@emory.edu

J Thromb Haemost ; 8(10): 2224-31, 2010 Oct.

Article en En | MEDLINE | ID: mdl-20704648

Asunto(s)

Factor VIII/inmunología; Hemofilia A/sangre; Hemofilia A/tratamiento farmacológico; Adulto; Factores de Edad; Anciano; Estudios de Casos y Controles; Factor VIII/uso terapéutico; Genotipo; Humanos; Masculino; Persona de Mediana Edad; Análisis Multivariante; Mutación Missense; Factores de Riesgo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factor VIII / Hemofilia A Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Año: 2010 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google